Announcement
01 Jan 2022
In 2022, the Chinese listed company Jilin Aodong Pharmaceutical Group Co.,Ltd. announced it had received USD 12 million of government subsidies.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
01 Jan 2022
Revocation date:
No revocation date
Updated: 01 Jan 2022
Financial grant
In force
In 2022, the Shenzhen-listed firm Jilin Aodong Pharmaceutical Group Co.,Ltd. (also known as JLAD) disclosed in its stock exchange filings the receipt of approximately USD 12 million of government subs...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.